Clinical trial JAVELIN BRCA/ATM
A Phase 2 Study to Evaluate Safety and Anti-tumor Activity of Avelumab in Combination with Talazoparib In Patients with BRCA or ATM Mutant Tumors - B9991032
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Pfizer |
| EudraCT Identifier | 2018-000345-39 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03565991 |
| Inclusion criteria | BRCA1 BRCA2 or ATM gene defect |
| Last update |